|
1
|
How can we increase participatory village interventions in active community involvement such as ACD and treatment?
|
18
|
|
2
|
How can we increase the quality and effectiveness of malaria education provided to patients by health facilities/VMWs, to improve awareness of, and prevention measures against malaria?
|
17
|
|
3
|
What are the most effective means of improving MMP Surveillance?
|
16
|
|
4
|
What are the most effective means of improving malaria case surveillance
|
16
|
|
5
|
Monitoring the efficacy of A + M for the treatment of Pf and Pv malaria cases
|
16
|
|
6
|
Evaluation of active surveillance and treatment of asymptomatic malaria cases
|
15
|
|
7
|
How has the epidemiology of vectors changed over the past 10 years?
|
15
|
|
8
|
How does DOTs change the behaviour of the patients and their adherence to anti-malarials?
|
15
|
|
9
|
How safe is primaquine administration in Cambodia, and what is the role of G6PD Screening?
|
15
|
|
10
|
Monitoring the efficacy of novel ACTs (Artesunate + Pyronaridine) in drug resistant regions of Cambodia
|
14
|
|
11
|
How effective are LLINs in protecting the most at risk populations (mobile migrant workers), and how does net preference and sleeping behaviour affect their use?
|
13
|
|
12
|
What is the prevalence of dengue and chikungunya in Cambodia?
|
12
|
|
13
|
How feasible is it to DOTs for malaria cases in Cambodia?
|
11
|
|
14
|
Is it feasible to use microscopy as a primary method of laboratory confirmed diagnosis for malaria and can a quality control program be established?
|
11
|
|
15
|
Is there a sustainable, effective and ecologically safe alternative to Abate for vector control measure for dengue control?
|
10
|
|
16
|
How can the capacity of the private sector be improved to incorporate NTD surveillance and the estimation of disease burden?
|
0
|
|
17
|
What surveillance and vector control methods are needed for NTDs in Cambodia?
|
0
|
